Why do enzymes activate inside the pancreas during pancreatitis?

Due to impaired secretion outflow (edema, trauma, obstruction), the enzyme cytokinase is activated. It converts proenzymes into active forms directly within the organ's tissue, bypassing the intestinal lumen.

Why is a tolerance test performed before administering protease inhibitors?

These drugs are protein-based (e.g., pantripin is extracted from cattle pancreas). They are foreign to the human body and carry a high risk of severe allergic reactions.

How do protease inhibitors affect blood clotting?

Aprotinin-based drugs reduce the fibrinolytic activity of blood by inhibiting plasmin. This produces a pronounced hemostatic effect, making them contraindicated in hypercoagulable states.

Home › Pharmacology › Protease Inhibitors

Protease Inhibitors

*Inhibitores proteolysis*

For medical students2 min readUpdated 2026-10-10

Protease inhibitors (antienzyme agents) are a pharmacological group designed to suppress the activity of pancreatic enzymes. They inactivate proteases in the blood and tissues, preventing organ destruction during acute inflammatory processes.

Main TargetCirculating trypsin and free kinins

Main RiskSevere allergic reactions due to protein nature

Route of AdministrationIntravenous infusion in high doses

Pathology MechanismAutolysis (self-digestion) of pancreatic tissues

Pathophysiological Rationale

Under normal physiological conditions, enzyme activation occurs within the intestinal lumen. However, pathological conditions disrupt secretion outflow. Causes of such duct obstruction include acute pancreatitis, exacerbation of chronic pancreatitis, trauma, pancreatic cancer, or edema of the duodenal wall (e.g., following alcohol consumption).

Secretion stasis activates a specific enzyme — cytokinase. This triggers a pathological cascade: proenzymes convert into active forms directly within the pancreatic tissue itself. The process of autolysis begins—rapid self-digestion of the pancreas and surrounding structures.

Pharmacodynamics and Therapeutic Effects

The action of antienzyme drugs aims at the emergency suppression of pancreatic enzyme activity. Their mechanism consists of two key processes:

Inactivation of trypsin already circulating in the systemic bloodstream.
Blocking free kinins—key mediators responsible for inflammation and pain.

This achieves significant therapeutic effects: toxemia is eliminated, and the destructive process (necrosis) in the pancreatic tissues stops progressing.

Key Pharmacological Agents

Clinical practice utilizes agents capable of inhibiting a broad spectrum of proteases.

Pantripin (Pantripinum). A polypeptide derived from bovine pancreatic tissue. It specifically binds and inhibits enzymes such as trypsin, chymotrypsin, kallikrein, and plasmin. Because it contains foreign animal protein, it carries a high risk of allergic reactions and is strictly contraindicated in individual hypersensitivity.
Aprotinin (trade names Gordox, Trasylol). Its mechanism of action is identical to pantripin. In addition to inhibiting proteolytic enzymes, aprotinin reduces the fibrinolytic activity of the blood, providing an additional hemostatic effect. Due to this property, the drug is strictly contraindicated in patients with hypercoagulability.

Administration Principles and Precautions

Achieving a pronounced antienzyme effect requires sufficiently high doses. They are administered exclusively via slow intravenous infusion. Either a 5% glucose solution or a 0.9% sodium chloride solution is used as a diluent.

Assessing individual tolerance prior to infusion is a critical step. Due to the protein nature of protease inhibitors, the risk of allergic reactions is extremely high, especially in patients with a history of allergies.

Mnemonic

To remember aprotinin effects, use the two "P" rule: it Prolonged Protease suppression (saving the pancreas from necrosis) and Plasmin suppression (stopping bleeding by reducing fibrinolytic activity).

Frequently asked questions

Why do enzymes activate inside the pancreas during pancreatitis?: Due to impaired secretion outflow (edema, trauma, obstruction), the enzyme cytokinase is activated. It converts proenzymes into active forms directly within the organ's tissue, bypassing the intestinal lumen.
Why is a tolerance test performed before administering protease inhibitors?: These drugs are protein-based (e.g., pantripin is extracted from cattle pancreas). They are foreign to the human body and carry a high risk of severe allergic reactions.
How do protease inhibitors affect blood clotting?: Aprotinin-based drugs reduce the fibrinolytic activity of blood by inhibiting plasmin. This produces a pronounced hemostatic effect, making them contraindicated in hypercoagulable states.

Go deeper

The role of cytokinase in the pathological cascade of pancreatic enzyme activation.
The mechanism of formation and action of free kinins in acute inflammation.
The link between plasmin inhibition and the hemostatic effect of aprotinin.
Differential selection of diluents (glucose vs. normal saline) for intravenous protein drug infusions.